Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

The Dark Forest theory is one proposed solution to the famed Fermi Paradox, which has bewitched astronomers for more than half a century. To put it concisely, the paradox asks if the cosmos is nearly ...

Challenger, Gray & Christmas said layoff plans totaled 71,321 in November, a step down from the massive cuts announced in ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...